Skip to main content

Month: March 2020

Share Buyback Transaction Details March 19 – 25, 2020

Share Buyback Transaction Details March 19 – 25, 2020Wolters Kluwer today reports that it has repurchased 146,990 of its own ordinary shares in the period from March 19, 2020, up to and including March 25, 2020, for €8.4 million and at an average share price of €57.47.These repurchases are part of the share buyback program announced on February 26, 2020, under which we intend to repurchase shares for up to €350 million during 2020.The cumulative amounts repurchased to date under this program are as follows:Share Buyback 2020For the period starting February 28, 2020, up to and including April 30, 2020, we have engaged a third party to execute €75 million of buybacks on our behalf, within the limits of relevant laws and regulations (in particular Regulation (EU) 596/2014) and the company’s Articles of Association.Repurchased shares...

Continue reading

Valmet to supply a hard nip sizer to Asia Paper Manufacturing in the Republic of Korea

Valmet Oyj’s press release on March 26, 2020 at 11:00 a.m. EETValmet will supply a new sizing section with a hard nip sizer to Asia Paper Manufacturing at Sihwa Mill in the Republic of Korea. The main target for the rebuild of paper machine PM 1 is to increase strength properties of produced container and gypsum board grades. The start-up of the rebuilt paper machine is scheduled for the second half of 2021.The order is included in Valmet’s orders received of the first quarter 2020. The value of the order will not be disclosed. The total value of an order of this type is typically around EUR 5-10 million.“Valmet was able to offer technical advantages to produce high quality gypsum and testliner board grades with low raw material cost. We were able to get proof for those targets as we run pilot trials at Valmet’s Paper Technology...

Continue reading

Valmet toimittaa kovanippisen pintaliimauslaitteen Asia Paper Manufacturingille Etelä-Koreaan

Valmet Oyj:n lehdistötiedote 26.3.2020 klo 11.00Valmet toimittaa uuden kovanippisen pintaliimauslaitteen Asia Paper Manufacturing -yrityksen Sihwan tehtaalle Etelä-Koreaan. Paperikone PM 1:n uusinnan päätavoite on lisätä valmistettavien ulkopakkaus- ja kipsikartonkilajien lujuusominaisuuksia. Uudelleenrakennettu paperikone on tarkoitus ottaa käyttöön vuoden 2021 jälkipuoliskolla.Tilaus sisältyy Valmetin vuoden 2020 ensimmäisen vuosineljänneksen saatuihin tilauksiin. Tilauksen arvoa ei julkisteta. Tämän tyyppisen tilauksen kokonaisarvo on tyypillisesti noin 5-10 miljoonaa euroa.”Valmet tarjosi teknologisesti edistyneitä ratkaisuja korkealaatuisten kipsi- ja testliner-kartonkilajien tuottamiseksi alhaisin raaka-ainekustannuksin. Saimme todennettua nämä koeajoissa Valmetin paperiteknologiakeskuksessa Suomessa. Vierailimme myös tehtaalla,...

Continue reading

Opera and Worldreader expand access to free ebooks for children and students in Africa during the Covid-19 outbreak

OSLO, Norway, March 26, 2020 (GLOBE NEWSWIRE) — Opera (NASDAQ: OPRA), one of the world’s leading browser providers, and international nonprofit organization, Worldreader, are expanding access to ebooks for children and students via the Opera Mini browser during the coronavirus outbreak.Starting this week, Worldreader will offer a new selection of ebooks to Opera Mini users as well as a new web app designed for children. The regular version of the Worldreader app will keep providing free ebooks for young adults with hundreds of books for learning and pleasure, in categories including Learn, Health, and Career. The new app BookSmart from Worldreader, will offer a wide variety of ebooks dedicated for children. Both apps can be accessed from the Opera Mini browser, after tapping on the Worldreader speed dial icon.“When considering how...

Continue reading

Natural Gas Generator Market to Reach USD 7.71 Billion by 2026; Increasing Investment in Product R&D to Aid Growth, says Fortune Business Insights™

Pune, March 26, 2020 (GLOBE NEWSWIRE) — The global natural gas generator market size is projected to reach USD 7.71 billion by the end of 2026. The increasing awareness regarding the use of natural gas and sustainable products will emerge in favor of market growth. According to a report by Fortune Business Insights, titled “Natural Gas Generator Market Size, Share and Industry Analysis, By Power Rating (Below 75kVA, 75-375kVA, 375-750kVA, Above 750kVA), By Application (Stand-by and Continuous), By End-User (Residential, Commercial, and Industrial), and Regional Forecast, 2019 – 2026,” the market was worth USD 4.81 billion in 2018 and will exhibit a CAGR of 6.2% during the forecast period, 2019-2026.A natural gas generator is a system that has the ability to produce electricity in cases of emergency and power shortages. It...

Continue reading

PCI Biotech: US patent for the vaccine technology (fimaVacc) with a new important class of adjuvants

Oslo (Norway), 26 March 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has informed the company that a new US patent will be granted early April 2020. The US patent covers the use of fimaVacc in combination with a new important class of vaccine adjuvants called toll like receptor agonists.Toll like receptor agonists (TLR agonists) is a diverse class of molecules that can be used for enhancing immune responses to several types of vaccines. TLR agonists have similarities to molecules present in various types of infectious agents, like viruses and bacteria, and can act as adjuvants to alert the immune system of a possible infection, thereby activating the immune system. The combination of TLR agonists with PCI Biotech’s vaccine technology, fimaVacc,...

Continue reading

Cortus första biosyngas i Höganäs

Cortus Energy har producerat den första ultrarena syngasen från biomassa i industriell skala vid den nybyggda förgasningsanläggningen i Höganäs.Cortus Energy (publ) har producerat den första syngasen vid anläggningen i Höganäs. Gasen är identisk med vad som tidigare producerats i pilotanläggningen i Köping, en ultraren syngas från biomassa som till fullo uppfyller leveransavtalet med Höganäs AB. Cortus försprång vad avser syngasens sammansättning, egenskaper och kvalité visar sig nu i en industriell skala. Denna första syngasproduktion är ett stort framsteg för Cortus. Uppskalningen av den patenterade processen respektive förgasningsreaktor och injektor motsvarar förväntningarna så här långt. Den ultrarena syngasen har producerats från char (träkol) som producerats vid vår pilotanläggning i Köping med biobränsle från Södra. Södra är leverantör...

Continue reading

ANNUAL REPORT 2019: WFD UNIBAIL-RODAMCO N.V. (EURONEXT: URW)

Amsterdam, March 26, 2020Press releaseANNUAL REPORT 2019: WFD UNIBAIL-RODAMCO N.V. (EURONEXT: URW)On March 25, 2020, WFD Unibail-Rodamco N.V. (“WFD UR NV”) released its Annual Report for the period ending December 31, 2019.The Annual Report for the period ending December 31, 2019, can be found on: http://www.wfd-unibail-rodamco-nv.com/en/investors.WFD UR NV and its consolidated entities, together with Unibail-Rodamco-Westfield SE (“URW SE”) and its consolidated entities, form Unibail-Rodamco-Westfield (“URW Group”). URW SE consolidates WFD UR NV and its controlled undertakings, and its Universal Registration Document including the accounts represent a comprehensive overview of URW, and is available on: www.urw.com/registrationdocument.For further information, please contact:Investor Relations                                          Media...

Continue reading

Nexstim Receives Two New NBS System Orders in the United States

Press release, Helsinki, 26 March 2020 at 9.30 am (EET)Nexstim Receives Two New NBS System Orders in the United StatesNexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) announces that it has recently received two new NBS System orders from two large medical institutions in the United States.Nexstim NBS System uses Company’s unique SmartFocus® TMS technology that enables accurate stimulation of the targeted area in patient’s brain. NBS System is the only FDA cleared system based on navigated Transcranial Magnetic Stimulation (nTMS) for non-invasive mapping of the speech and motor cortices of the brain. Nexstim NBS systems are used mainly for neurosurgical diagnostics: One of the most crucial pieces of information needed for neurosurgery is the tumour’s location in relation to the essential functions and...

Continue reading

Borregaard ASA: Annual Report 2019

Borregaard’s Annual Report for 2019, which also includes the Sustainability Report, is published today.To order a printed copy, please go to www.borregaard.com. A pdf-version is attached.Borregaard ASASarpsborg, 26 March 2020Contacts:Tone Horvei Bredal, Communication Manager, +47 92 46 77 11Lotte Kvinlaug, Investor Relations Officer, +47 92 28 69 09This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.AttachmentAnnual Report 2019

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.